Back Article

  • [1]

    Wei Chen, Pengmian Feng, Kewei Liu, Meng Wu, Hao Lin, 2020: Computational Identification of Small Interfering RNA Targets in SARS-CoV-2, Virologica Sinica, 35, 359-361. doi: 10.1007/s12250-020-00221-6

  • [2]

    Tiandan Xiang, Junzhong Wang, Xin Zheng, 2022: The humoral and cellular immune evasion of SARS-CoV-2 Omicron and sub-lineages, Virologica Sinica, 37, 786-795. doi: 10.1016/j.virs.2022.11.007

  • [3]

    Yongran Wu, Ke Hong, Lianguo Ruan, Xiaobo Yang, Jiancheng Zhang, Jiqian Xu, Shangwen Pan, Lehao Ren, Lu Chen, Chaolin Huang, You Shang, 2020: Patients with Prolonged Positivity of SARS-CoV-2 RNA Benefit from Convalescent Plasma Therapy: A Retrospective Study, Virologica Sinica, 35, 768-775. doi: 10.1007/s12250-020-00281-8

  • [4]

    Xiaohui Zou, Shengrui Mu, Yeming Wang, Li Guo, Lili Ren, Xiaoyan Deng, Haibo Li, Jiankang Zhao, Yulin Zhang, Hui Li, Binghuai Lu, Chaolin Huang, Bin Cao, 2022: Characterization of two SARS-CoV-2 subgenomic RNA dynamics in severe COVID-19 patients, Virologica Sinica, 37, 30-37. doi: 10.1016/j.virs.2022.01.008

  • [5]

    Jun-Bo Zhou, Wen-Hua Kong, Sheng Wang, Yi-Bing Long, Lian-Hua Dong, Zhen-Yu He, Man-Qing Liu, 2021: Detection of SARS-CoV-2 RNA in Medical Wastewater in Wuhan During the COVID-19 Outbreak, Virologica Sinica, 36, 1077-1079. doi: 10.1007/s12250-021-00373-z

  • [6]

    Kangyin Li, Qi Liu, Yan Wu, Bihao Wu, Shaohong Chen, Xinghai Zhang, Xiaoying Jia, Rui Gong, Yucai Peng, Huajun Zhang, Sandra Chiu, 2024: A bivalent Delta/BA.5 mRNA vaccine elicits broad immune responses against various lineages of SARS-CoV-2 including JN.1, Virologica Sinica, 39, 833-835. doi: 10.1016/j.virs.2024.08.003

  • [7]

    Yuanyuan Qu, Xueyan Zhang, Meiyu Wang, Lina Sun, Yongzhong Jiang, Cheng Li, Wei Wu, Zhen Chen, Qiangling Yin, Xiaolin Jiang, Yang Liu, Chuan Li, Jiandong Li, Tianlei Ying, Dexin Li, Faxian Zhan, Youchun Wang, Wuxiang Guan, Shiwen Wang, Mifang Liang, 2021: Antibody Cocktail Exhibits Broad Neutralization Activity Against SARS-CoV-2 and SARS-CoV-2 Variants, Virologica Sinica, 36, 934-947. doi: 10.1007/s12250-021-00409-4

  • [8]

    Shi-Zhe Xie, Mei-Qin Liu, Ren-Di Jiang, Hao-Feng Lin, Wei Zhang, Bei Li, Jia Su, Fei Ke, Qi-Ya Zhang, Zheng-Li Shi, Xing-Lou Yang, 2022: Fish ACE2 is not susceptible to SARS-CoV-2, Virologica Sinica, 37, 142-144. doi: 10.1016/j.virs.2022.01.020

  • [9]

    Ashutosh Singh, Rahul Soloman Singh, Phulen Sarma, Gitika Batra, Rupa Joshi, Hardeep Kaur, Amit Raj Sharma, Ajay Prakash, Bikash Medhi, 2020: A Comprehensive Review of Animal Models for Coronaviruses: SARS-CoV-2, SARS-CoV, and MERS-CoV, Virologica Sinica, 35, 290-304. doi: 10.1007/s12250-020-00252-z

  • [10]

    Anthony T. Tan, Joey Ming Er Lim, Antonio Bertoletti, 2022: Protection from infection or disease? Re-evaluating the broad immunogenicity of inactivated SARS-CoV-2 vaccines, Virologica Sinica, 37, 783-785. doi: 10.1016/j.virs.2022.11.002

  • [11]

    Haiyan Shen, Yanxing Cai, Huan Zhang, Jie Wu, Lin Ye, Penghui Yang, Xiaojun Lin, Shibo Jiang, Ming Liao, 2021: Anti-SARS-CoV-2 IgY Isolated from Egg Yolks of Hens Immunized with Inactivated SARS-CoV-2 for Immunoprophylaxis of COVID-19, Virologica Sinica, 36, 1080-1082. doi: 10.1007/s12250-021-00371-1

  • [12]

    Li Zhao, Ruqin Gao, Roujian Lu, Huijuan Wang, Yao Deng, Peihua Niu, Fachun Jiang, Baoying Huang, Jiwei Liang, Jing Jia, Feng Zhang, Wenling Wang, Guizhen Wu, Wenjie Tan, 2021: Profiles of SARS-CoV-2 RNA and Antibodies in Inpatients with COVID-19 not Related with Clinical Manifestation: A Single Centre Study, Virologica Sinica, 36, 1088-1092. doi: 10.1007/s12250-021-00411-w

  • [13]

    Xiao Hu, Zhen Chen, Zhengyuan Su, Fei Deng, Xinwen Chen, Qi Yang, Pan Li, Quanjiao Chen, Jun Ma, Wuxiang Guan, Rongjuan Pei, Yun Wang, 2021: Ozone Water Is an Effective Disinfectant for SARS-CoV-2, Virologica Sinica, 36, 1066-1068. doi: 10.1007/s12250-021-00379-7

  • [14]

    Hou-Li Cai, Yao-Wei Huang, 2023: Reverse genetics systems for SARS-CoV-2: Development and applications, Virologica Sinica, 38, 837-850. doi: 10.1016/j.virs.2023.10.001

  • [15]

    Xiao-Li Feng, Dandan Yu, Mi Zhang, Xiaohong Li, Qing-Cui Zou, Wentai Ma, Jian-Bao Han, Ling Xu, Cuixian Yang, Wang Qu, Zhong-Hua Deng, Junyi Long, Yanghaopeng Long, Mingkun Li, Yong-Gang Yao, Xing-Qi Dong, Jianxiong Zeng, Ming-Hua Li, 2022: Characteristics of replication and pathogenicity of SARS-CoV-2 Alpha and Delta isolates, Virologica Sinica, 37, 804-812. doi: 10.1016/j.virs.2022.09.007

  • [16]

    Kai Wu, Dehe Wang, Junhao Wang, Yu Zhou, 2022: Translation landscape of SARS-CoV-2 noncanonical subgenomic RNAs, Virologica Sinica, 37, 813-822. doi: 10.1016/j.virs.2022.09.003

  • [17]

    Ge Gao, Xue Hu, Yiwu Zhou, Juhong Rao, Xiaoyu Zhang, Yun Peng, Jiaxuan Zhao, Yanfeng Yao, Kunpeng Liu, Mengying Liang, Hang Liu, Fei Deng, Han Xia, Chao Shan, Zhiming Yuan, 2022: Infection and pathogenesis of the Delta variant of SARS-CoV-2 in Rhesus macaque, Virologica Sinica, 37, 299-302. doi: 10.1016/j.virs.2022.02.001

  • [18]

    Zaira Rehman, Massab Umair, Aamer Ikram, Ammad Fahim, Muhammad Salman, 2022: Footprints of SARS-CoV-2 genome diversity in Pakistan, 2020–2021, Virologica Sinica, 37, 153-155. doi: 10.1016/j.virs.2022.01.009

  • [19]

    Changhua Yi, Yongxiang Yi, Junwei Li, 2020: mRNA Vaccines: Possible Tools to Combat SARS-CoV-2, Virologica Sinica, 35, 259-262. doi: 10.1007/s12250-020-00243-0

  • [20]

    Sissy Therese Sonnleitner, Stefanie Sonnleitner, Eva Hinterbichler, Hannah Halbfurter, Dominik B.C. Kopecky, Stephan Koblmüller, Christian Sturmbauer, Wilfried Posch, Gernot Walder, 2022: The mutational dynamics of the SARS-CoV-2 virus in serial passages in vitro, Virologica Sinica, 37, 198-207. doi: 10.1016/j.virs.2022.01.029